Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease

Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease

Parkinson's disease is a common multisystem neurodegenerative disorder characterized by typical motor and non-motor symptoms. There is an urgent need for biomarkers for assessment of disease severity, complications and prognosis. In addition, biomarkers reporting the underlying pathophysiology...

Full description

Bibliographic Details
Main Authors:	Tino Prell, Otto W. Witte, Julian Grosskreutz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-03-01
Series:	Frontiers in Neurology
Subjects:	Parkinson's disease biomarker non-motor syndromes depression fatigue dementia
Online Access:	https://www.frontiersin.org/article/10.3389/fneur.2019.00195/full

Similar Items

Impact of subthreshold depression on health-related quality of life in patients with Parkinson’s disease based on cognitive status
by: Aline Schönenberg, et al.
Published: (2021-03-01)

What Predicts Different Kinds of Nonadherent Behavior in Elderly People With Parkinson's Disease?
by: Sarah Mendorf, et al.
Published: (2020-03-01)

Association Between Nonmotor Symptoms and Nonadherence to Medication in Parkinson's Disease
by: Sarah Mendorf, et al.
Published: (2020-10-01)

Ultrasonography of the Vagus Nerve in Parkinson's Disease
by: Nadin Fedtke, et al.
Published: (2018-07-01)

Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson's disease: A cross-sectional study.
by: Maria Theresa Gruber, et al.
Published: (2020-01-01)

Sicca Symptoms in Parkinson’s Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life
by: Tino Prell, et al.
Published: (2020-01-01)

Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis
by: Tino Prell, et al.
Published: (2019-09-01)

Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease
by: Caroline Perner, et al.
Published: (2019-05-01)

Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging
by: Tino Prell, et al.
Published: (2019-01-01)

Data on adherence to medication in neurological patients using the German Stendal Adherence to Medication Score (SAMS)
by: Tino Prell, et al.
Published: (2019-04-01)

Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data
by: Tino Prell, et al.
Published: (2020-05-01)

Depression and Dementia in Parkinson’s Disease
by: Osman Sinanović, et al.
Published: (2015-01-01)

Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson’s Disease
by: Tino Prell
Published: (2018-03-01)

DEPRESSION IN PATIENTS WITH PARKINSON'S DISEASE WITH DEMENTIA
by: Zlatana Perovic, et al.
Published: (2017-04-01)

The impact of loneliness on quality of life in people with Parkinson’s disease: results from the Survey of Health, Ageing and Retirement in Europe
by: Tino Prell, et al.
Published: (2023-06-01)

Disease Specific Aspects of Malnutrition in Neurogeriatric Patients
by: Tino Prell, et al.
Published: (2018-03-01)

Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness
by: Nora Dieckmann, et al.
Published: (2022-01-01)

Poor sleep quality is associated with fatigue and depression in early Parkinson's disease: A longitudinal study in the PALS cohort
by: Matthew Rui En Koh, et al.
Published: (2022-09-01)

Short- and Long-Term Effect of Parkinson’s Disease Multimodal Complex Treatment
by: Konstantin G. Heimrich, et al.
Published: (2021-11-01)

Frontal Transcranial Direct Current Stimulation as a Potential Treatment of Parkinson’s Disease-Related Fatigue
by: Tino Zaehle
Published: (2021-04-01)

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
by: Marie Dreger, et al.
Published: (2021-04-01)

Data on the effect of Parkinson's disease multimodal complex treatment in a German University Hospital
by: Konstantin G. Heimrich, et al.
Published: (2022-10-01)

Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
by: Prell T, et al.
Published: (2019-01-01)

Association between different coping styles and health-related quality of life in people with Parkinson’s disease: a cross-sectional study
by: Tino Prell, et al.
Published: (2020-07-01)

Blood–Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis
by: Tino Prell, et al.
Published: (2021-10-01)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
by: Robert Steinbach, et al.
Published: (2021-01-01)

Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients
by: Caroline Perner, et al.
Published: (2018-03-01)

Fatigue in Parkinson’s disease—A narrative review
by: Baikuntha Panigrahi, et al.
Published: (2024-12-01)

Is Depression or Apathy Playing a Key Role in Predicting Financial Capacity in Parkinson’s Disease with Dementia and Frontotemporal Dementia?
by: Vaitsa Giannouli, et al.
Published: (2021-06-01)

Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson’s Disease
by: Francis Feldmann, et al.
Published: (2020-01-01)

Longitudinal analysis of the Non-Motor Symptoms Scale in Parkinson's Disease (NMSS): An exploratory network analysis approach
by: Konstantin G. Heimrich, et al.
Published: (2023-02-01)

Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson’s Disease
by: Hannah M. Zipprich, et al.
Published: (2021-02-01)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
by: Massimo Filippi, et al.
Published: (2023-09-01)

Fatigue in Brazilian patients with Parkinson’s disease
by: Daniel Venturino Nassif, et al.
Published: (2022-05-01)

Gait Characteristics Associated with Fear of Falling in Hospitalized People with Parkinson’s Disease
by: Manuela Uhlig, et al.
Published: (2023-01-01)

Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
by: Priyadarshi Prajjwal, et al.
Published: (2024-04-01)

Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson’s disease
by: Maritza eSandoval-Rincón, et al.
Published: (2015-03-01)

An examination of anxiety and its influence on health-related quality of life in Parkinson’s disease using the geriatric anxiety scale: a cross-sectional study
by: Konstantin G. Heimrich, et al.
Published: (2024-03-01)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
by: Per Svenningsson, et al.
Published: (2017-06-01)

Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
by: Sanskriti Sasikumar, et al.
Published: (2020-01-01)